Astrana Health (ASTH) Depreciation & Amortization (CF) (2012 - 2026)

Astrana Health has reported Depreciation & Amortization (CF) for 17 years, with the latest figure at $15.5 million in Q1 2026.

• Quarterly Depreciation & Amortization (CF) rose 126.0% year-over-year to $15.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $54.4 million (up 83.22% YoY) and the FY2025 annual result came in at $45.7 million, up 63.82% from the prior year.
• Depreciation & Amortization (CF) declined to $15.5 million in Q1 2026 per ASTH's latest filing, from $16.4 million in the prior quarter.
• Over five years, Depreciation & Amortization (CF) peaked at $16.4 million in Q4 2025 and troughed at $4.1 million in Q4 2022.
• A 5-year average of $7.3 million and a median of $5.1 million in 2024 frame the typical range for Depreciation & Amortization (CF).
• The sharpest annual moves came in 2023 and 2026: Depreciation & Amortization (CF) declined 9.46% in 2023, then surged 126.0% in 2026.
• Over 5 years, Depreciation & Amortization (CF) stood at $4.1 million in 2022, then gained by 20.65% to $4.9 million in 2023, then jumped by 65.77% to $8.1 million in 2024, then jumped by 101.83% to $16.4 million in 2025, then retreated by 5.62% to $15.5 million in 2026.
• According to Business Quant data, Depreciation & Amortization (CF) over the past three periods registered $15.5 million, $16.4 million, and $15.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.